产品: Nav1.6/SCN8A 抗体
货号: DF8577
描述: Rabbit polyclonal antibody to Nav1.6/SCN8A
应用: WB IHC IF/ICC
文献验证: WB
反应: Human, Mouse, Rat
预测: Pig, Bovine, Horse, Sheep, Rabbit, Dog
蛋白号: Q9UQD0
RRID: AB_2841781

浏览相似产品>>

   规格 价格 库存
 50ul RMB¥ 1500 现货
 100ul RMB¥ 2300 现货
 200ul RMB¥ 3000 现货

货期: 当天发货

联系销售

产品描述

来源:
Rabbit
应用:
IHC 1:50-1:200, WB 1:1000-3000, IF/ICC 1:100-1:500
*The optimal dilutions should be determined by the end user.
*Tips:

WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.

反应:
Human, Mouse, Rat
克隆:
Polyclonal
特异性:
Nav1.6/SCN8A Antibody detects endogenous levels of total Nav1.6/SCN8A.
RRID:
AB_2841781
引用格式: Affinity Biosciences Cat# DF8577, RRID:AB_2841781.
偶联:
Unconjugated.
纯化:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
别名:

展开/折叠

CerIII; CIAT; EIEE13; hNa6/Scn8a voltage gated sodium channel; MED; Motor endplate disease; NaCh 6; NaCh6; Nav 1.6; Nbna1; peripheral nerve protein type 4; PN 4; PN4; SCN8A; SCN8A_HUMAN; Sodium channel protein type 8 alpha subunit; Sodium channel protein type 8 subunit alpha; Sodium channel protein type VIII alpha subunit; Sodium channel protein type VIII subunit alpha; Sodium channel voltage gated type VIII alpha; Sodium channel voltage gated type VIII alpha polypeptide; Sodium channel voltage gated type VIII alpha subunit; Voltage gated sodium channel subunit alpha Nav1.6; Voltage-gated sodium channel subunit alpha Nav1.6;

抗原和靶标

免疫原:

A synthesized peptide derived from human Nav1.6/SCN8A, corresponding to a region within the internal amino acids.

基因/基因ID:

文献引用

1). Lidocaine inhibits influenza a virus replication by up-regulating IFNα4 via TBK1-IRF7 and JNK-AP1 signaling pathways. International Immunopharmacology, 2023 (PubMed: 36638664) [IF=4.8]

2). LncRNA01103/FGF13 axis promotes the progression of bone cancer pain by remodeling ac4C modification. Research Square, 2024

Application: WB    Species: Rat    Sample:

Figure 7. FGF13 participates in BCP by regulating sodium channels. (A) qPCR for monitoring FGF13-siRNA (siRNAFgf13) in RT4-D6P2T cells to validate transfection efficiency. Bars represent the means ± SEM of independent biological replicates (n = 3). Values of individual experiments are indicated as dots. P-values were calculated using the one-way ANOVA (**P < 0.01; ***P < 0.001). (B) Western blots for monitoring transfection efficiency of siRNAFgf13 in BCP rat SDH were validated. Bars represent the means ± SEM of independent biological replicates (n = 3). Values of individual experiments are indicated as dots. P-values were calculated using the one-way ANOVA (***P < 0.001). (C) Reducing Fgf13 expression attenuates mechanical nociceptive sensitization in BCP rats. Bars represent the means ± SEM of independent biological replicates (n = 8). P-values were calculated using the two-way repeated measures analysis (###P < 0.001). PWT: Paw withdrawal threshold. (D) Statistical plots of the number of buried strains in Sham, BCP+siRNANC and BCP+ siRNAFgf13 groups. Bars represent the means ± SEM of independent biological replicates (n = 8). Values of individual experiments are indicated as dots. P-values were calculated using the one-way ANOVA (**P < 0.01; ***P < 0.001). (E-G) Representative CatWalk gait, including footprint area and mean intensity (E), in Sham, BCP+ siRNANC and BCP+ siRNAFgf13 groups. Quantifications of mean intensity (LH/RH) (F) and print area (LH/RH) (G) in both groups of rats. Bars represent the means ± SEM of independent biological replicates (n = 8). Values of individual experiments are indicated as dots. P-values were calculated using the Student's t test (**P < 0.01; ***P < 0.001). LH, left hind paw; RH, right hind paw. (H-J) Representative traces of locomotor activity in the light-dark transition (LDT) (H) in Sham group, BCP+siRNANC group and BCP+siRNAFgf13 group rats. Quantifications of time spent (I) and distance (J) in the light chamber. Bars represent the means ± SEM of independent biological replicates (n = 8). Values of individual experiments are indicated as dots. P-values were calculated using the one-way ANOVA (**P < 0.01; ***P < 0.001). (K-L) Representative traces of Elevated plus- maze (EPM) (K) in Sham group, BCP+siRNANC group and BCP+siRNAFgf13 group rats. Quantifications of time spent (L) in the open arms. Bars represent the means ± SEM of independent biological replicates (n = 8). Values of individual experiments are indicated as dots. P-values were calculated using the one-way ANOVA (***P < 0.001). (M-P) Western blots for monitoring the effect of siRNAFgf13 on the expression of Nav1.1, Nav1.6, Nav1.7, Nav1.8 in the SDH of BCP rats. ß-Actin served as loading control. Bars represent the means ± SEM of independent biological replicates (n = 4). Values of individual experiments are indicated as dots. P-values were calculated using the one-way ANOVA (*P < 0.05; **P < 0.01).

限制条款

产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)

产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。

产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。

Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。

产品仅供科学研究使用。不用于诊断和治疗。 

产品未经授权不得转售。

Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.